|
⚲
|
| Keyboard |
| GNI USA Inc
✚
|
|
|---|---|
| CIK # | 0001973229, 0001958461 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001958461] | |
| 4 | [0001958461] | |
| SC 13D | [0001958461] | |
| 3 | [0001973229] | |
| 4 | [0001973229] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| GNI Group Ltd | Catalyst Biosciences Inc | [2023-01-05] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| GNI Group Ltd | |
| GNI USA Inc | |
| GYRE Therapeutics Inc | |
| GNI Hong Kong Ltd |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
GYRE Therapeutics Inc GYRE
Common Stock
|
2023-10-30 | Other | 63,588,119 | ||
|
GYRE Therapeutics Inc GYRE
Series X Convertible Preferred Stock · derivative
|
2023-10-27 | Buy | 811 | $4,915.00 | 3,986,065 |
|
GYRE Therapeutics Inc GYRE
Series X Convertible Preferred Stock Warrant (Right to Buy) · derivative
|
2023-10-27 | Buy | 8,110,300 | $0.13 | 1,054,339 |
|
GYRE Therapeutics Inc CBIO
Series Y Preferred Stock
|
2023-08-31 | Disposed to issuer | 5,371.30 | ||
|
GYRE Therapeutics Inc CBIO
Series Y Preferred Stock
|
2023-08-31 | Disposed to issuer | 895.22 |